2013-05-03 13:22:54 - New Medical Devices research report from GlobalData is now available from Fast Market Research
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Improved surveillance in developing countries has allowed the identification of more women with breast cancer in these regions. Early diagnosis of breast cancer is essential for a good prognosis, making diagnosis a cornerstone of breast cancer control. Predictive gene testing can identify women who are at heightened risk of developing breast cancer due to hereditary gene factors. This report focuses on the predictive breast cancer gene testing markets in the US and Europe, and future markets in China, India and Brazil,
identifying and competitively assessing current marketed and pipeline products and emerging technologies.
This report identifies the unmet needs in the market, provides an understanding of physician perception of predictive breast cancer gene testing, and future trends. Through GlobalData's analysis, it is evident that the predictive breast cancer gene testing market is dominated by a single player, but this may change in the near future thanks to expiry of key patents and the emergence of new DNA sequencing technologies. To successfully market new gene tests, companies need to offer gene tests that address the current unmet needs of current predictive breast cancer gene tests and show better efficacy and cost effectiveness to the gene tests currently in the market. This report will identify the opportunities for this technology.
Full Report Details at
- www.fastmr.com/prod/591979_medipoint_predictive_breast_cancer_ge ..
* Investigation of current and future market competition for predictive breast cancer gene testing.
* Competitor assessment.
* Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
* Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
* Direct quotes from Key Opinion Leaders (KOL) as well as oncologists, geneticists and genetic counselors already using these gene tests.
Reasons to buy
* Gain a high level view of the trends shaping and driving the predictive breast cancer gene testing market.
* Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
* Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
* Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
* Create an effective counter-strategy to gain a competitive advantage against those currently in the market
Companies Mentioned in this Report: Myriad Genetics, Ambry Genetics, Complete Genomics, Navigenics (now Life Technologies), PreventionGenetics, Lab21 Ltd., NewGene Ltd., The Doctors Laboratory Ltd., Bioscientia GmBH, Centogene AG (Centogene Rostock G, Sistemas Genomicos, Grupo Fleury, Diagnosticos da America SA (DASA), ATS GeneTech, 23AndMe, BGI-Shenzhen, Illumina, Life Technologies, Roche
Partial Table of Contents:
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
3 Competitive Assessment 9
3.1 Overview 9
3.1.1 BRACAnalysis 10
3.1.2 BreastNext 18
3.1.3 BreastCancer 24
3.1.4 PreventionGenetics CHEK2/BARD1 Sequencing 26
3.1.5 NewGene NGS BRCA1/2 29
3.1.6 TDL BRCA1/2 Full Screening 31
3.1.7 Centogene Breast Ovarian Cancer NGS Panel 33
3.1.8 Mamma GeneProfile 36
3.1.9 23AndMe DNA Spit Kit 38
3.1.10 DeCodeMe Complete Scan 44
3.1.11 Health Compass 46
4 Pipeline Products 48
4.1 Predictive Breast Cancer Gene Tests in Development 48
4.1.1 Myriad Genetics RAD51C Breast Cancer Gene Test 49
4.1.2 23AndMe Exome 80X 50
4.2 Breast Cancer Gene Expression Tests 50
4.2.1 BreastGeneDX 51
4.2.2 Diagnostic Test - Breast Cancer (Queens University/Almac Diagnostics) 52
4.2.3 Diagnostic Test - Breast Cancer (NanoIVD) 53
4.2.4 EpiSwitch OBD27 54
4.2.5 Myriad HRD Test 55
4.2.6 PAM50 Breast Cancer Test 56
4.3 Emerging Sequencing Technology 57
4.4 New Gene Discovery 57
5 Current and Future Players 58
5.1 Overview 58
5.2 Trends in Corporate Strategy 59
5.3 Common Strengths, Weaknesses, Opportunities and Threats 60
5.3.1 Growing Incidence of Breast Cancer 60
5.3.2 Growing Market Opportunities in Emerging Markets 61
5.3.3 Uncertain R&D Outcomes 62
5.3.4 Stringent Government Regulations 62
5.4 Company Profiles 63
5.4.1 Myriad Genetics 63
5.4.2 Ambry Genetics 74
5.4.3 Complete Genomics 78
5.4.4 Navigenics (now Life Technologies) 83
5.4.5 PreventionGenetics 87
5.4.6 Lab21 Ltd. 89
5.4.7 NewGene Ltd. 93
5.4.8 The Doctors Laboratory Ltd. 96
5.4.9 Bioscientia GmBH 99
5.4.10 Centogene AG (Centogene Rostock GmBH) 101
5.4.11 Sistemas Genomicos 103
5.4.12 Grupo Fleury 106
5.4.13 Diagnosticos da America SA (DASA) 109
5.4.14 ATS GeneTech 112
5.4.15 23AndMe 116
5.4.16 BGI-Shenzhen 125
5.4.17 Illumina 129
5.4.18 Life Technologies 137
5.4.19 Roche 143
6 Appendix 147
6.1 Bibliography 147
6.2 Abbreviations 162
6.3 Research Methodology 164
6.3.1 Overview 164
6.3.2 Coverage 164
6.3.3 Secondary Research 165
6.3.4 Forecast Methodology 165
6.4 Physicians and Specialists Included in this Study 167
Full Table of Contents is available at:
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.